These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 6174240)

  • 1. Location of the cell-attachment site in fibronectin with monoclonal antibodies and proteolytic fragments of the molecule.
    Pierschbacher MD; Hayman EG; Ruoslahti E
    Cell; 1981 Oct; 26(2 Pt 2):259-67. PubMed ID: 6174240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification with monoclonal antibodies of different regions of human plasma fibronectin, including that which interacts with human monocyte fibronectin receptors.
    Czop JK; Kadish JL; Zepf DM; Austen KF
    Immunology; 1985 Mar; 54(3):407-17. PubMed ID: 2579023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the heparin binding domain of fibronectin in attachment and spreading of human bone-derived cells.
    Dalton BA; McFarland CD; Underwood PA; Steele JG
    J Cell Sci; 1995 May; 108 ( Pt 5)():2083-92. PubMed ID: 7657726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Domain structure of human plasma and cellular fibronectin. Use of a monoclonal antibody and heparin affinity to identify three different subunit chains.
    Click EM; Balian G
    Biochemistry; 1985 Nov; 24(23):6685-96. PubMed ID: 2417623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of two unique heparin binding domains of human plasma fibronectin with monoclonal antibodies.
    Smith DE; Furcht LT
    J Biol Chem; 1982 Jun; 257(11):6518-23. PubMed ID: 6176583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization and chemical synthesis of fibronectin peptides with melanoma adhesion and heparin binding activities.
    McCarthy JB; Chelberg MK; Mickelson DJ; Furcht LT
    Biochemistry; 1988 Feb; 27(4):1380-8. PubMed ID: 2966638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody against human fibronectin which inhibits cell attachment.
    Schoen RC; Bentley KL; Klebe RJ
    Hybridoma; 1982; 1(2):99-108. PubMed ID: 6208125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibronectin's cell-adhesive domain and an amino-terminal matrix assembly domain participate in its assembly into fibroblast pericellular matrix.
    McDonald JA; Quade BJ; Broekelmann TJ; LaChance R; Forsman K; Hasegawa E; Akiyama S
    J Biol Chem; 1987 Mar; 262(7):2957-67. PubMed ID: 3818629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alignment of biologically active domains in the fibronectin molecule.
    Ruoslahti E; Hayman EG; Engvall E; Cothran WC; Butler WT
    J Biol Chem; 1981 Jul; 256(14):7277-81. PubMed ID: 6788765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and biological interactions of fibronectin.
    Ruoslahti E; Pierschbacher M; Engvall E; Oldberg A; Hayman EG
    J Invest Dermatol; 1982 Jul; 79 Suppl 1():65s-68s. PubMed ID: 7045246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix-driven translocation: dependence on interaction of amino-terminal domain of fibronectin with heparin-like surface components of cells or particles.
    Newman SA; Frenz DA; Hasegawa E; Akiyama SK
    Proc Natl Acad Sci U S A; 1987 Jul; 84(14):4791-5. PubMed ID: 2440029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies to the collagen binding domain of human plasma fibronectin.
    Tarone G; Amedeo MR; Di Renzo MF; Comoglio P
    Exp Cell Biol; 1984; 52(4):225-36. PubMed ID: 6203785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction of fibronectin fragments with fibroblastic cells.
    Akiyama SK; Hasegawa E; Hasegawa T; Yamada KM
    J Biol Chem; 1985 Oct; 260(24):13256-60. PubMed ID: 2932436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformational transitions in the cell binding domain of fibronectin.
    Ugarova TP; Zamarron C; Veklich Y; Bowditch RD; Ginsberg MH; Weisel JW; Plow EF
    Biochemistry; 1995 Apr; 34(13):4457-66. PubMed ID: 7535564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human placental (fetal) fibronectin: increased glycosylation and higher protease resistance than plasma fibronectin. Presence of polylactosamine glycopeptides and properties of a 44-kilodalton chymotryptic collagen-binding domain: difference from human plasma fibronectin.
    Zhu BC; Fisher SF; Pande H; Calaycay J; Shively JE; Laine RA
    J Biol Chem; 1984 Mar; 259(6):3962-70. PubMed ID: 6423638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective interaction of peripheral and central nervous system cells with two distinct cell-binding domains of fibronectin.
    Rogers SL; Letourneau PC; Peterson BA; Furcht LT; McCarthy JB
    J Cell Biol; 1987 Sep; 105(3):1435-42. PubMed ID: 2958484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A difference between plasma and cellular fibronectins located with monoclonal antibodies.
    Atherton BT; Hynes RO
    Cell; 1981 Jul; 25(1):133-41. PubMed ID: 6168385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological cross-reactivity between human tripeptidyl peptidase II and fibronectin.
    Tomkinson B; Zetterqvist O
    Biochem J; 1990 Apr; 267(1):149-54. PubMed ID: 1691635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody against the N-terminal end of human plasma fibronectin.
    Vartio T; Salonen EM; De Petro G; Barlati S; Miggiano V; Stähli C; Virgallita G; Takács B; Vaheri A
    Biochem J; 1983 Oct; 215(1):147-51. PubMed ID: 6194791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural analysis of fibronectin with monoclonal antibodies.
    Atherton BT; Taylor DM; Hynes RO
    J Supramol Struct Cell Biochem; 1981; 17(2):153-61. PubMed ID: 7321057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.